Imaging and liquid biopsy for glioma diagnosis and treatment monitoring
Ended Project Grant Awarded Last action
- Award ID
- R01CA239078
- Recipient
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,094,732
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $30,452 | |
| Amendment | $548,141 | |
| Amendment | $605,638 | |
| Amendment | $50,146 | |
| Amendment | $564,107 | |
| Amendment | $635,399 | |
| Original award | $660,849 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Exosome Diagnostics Inc. | $209,273 |
Quick answers
Who received award R01CA239078?
R01CA239078 was awarded to The General Hospital Corporation by National Cancer Institute (National Institutes of Health) on March 1, 2020.
How much is award R01CA239078 worth?
$3,094,732 has been obligated on R01CA239078.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award